< Back to previous page
Researcher
Isabelle Huys
- Disciplines:Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Clinical Pharmacology and Pharmacotherapy (Division)
Responsible
From17 Dec 2020 → Today - Faculty of Law and Criminology (Faculty)
Member
From1 Oct 2014 → 30 Sep 2015 - Clinical Pharmacology and Pharmacotherapy (Division)
Member
From1 Jul 2013 → Today - Toxicology and Pharmacology (Division)
Member
From1 Oct 1999 → 9 Mar 2004
Projects
11 - 20 of 50
- NEED for rare conditions. Identification of unmet patient and societal needs in healthcare - Applicability of a framework to rare diseasesFrom2 May 2023 → 26 Mar 2024Funding: Belgian Health Care Knowledge Centre (KCE)
- Gene Therapy for treatment of rare inherited Arrhythmogenic CardiomyopathyFrom1 May 2023 → TodayFunding: HORIZON.2.1 - Health
- Development, Validation, and Valorization of a Patient Preference Platform to Inform Healthcare Decision-MakingFrom1 Mar 2023 → TodayFunding: IOF - technology validation in lab
- The Impact of SARS-CoV-2 Vaccine R&D decisions on the downstream Covid-19 Immunization System - Improving Strategic and Operational Preparedness for Future Virus Crisis OutbreakFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- European Cancer Imaging InitiativeFrom1 Jan 2023 → TodayFunding: Digital Europe Programme (DIGITAL)
- Optimizing the conduct and implementation of patient preference research in drug development and evaluation: a focus on oncology and COVID-19From22 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Exploring the market environment of biologics including biosimilar medicinesFrom20 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Policy recommendations for a pharmaceutical R&D and evaluation framework that is driven by unmet medical needsFrom15 Sep 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Integrating shared decision making in Belgian clinical practiceFrom10 Sep 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Framework for value driven market access of gene therapyFrom1 Sep 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 213
- Testing and Practical Implementation of a User-Friendly Personalized and Long-Term Electronic Informed Consent Prototype in Clinical Research: Mixed Methods Study(2023)
Authors: David Geerts, Koen Yskout, Stef Verreydt, Pascal Borry, Liese Barbier, Isabelle Huys
- Unlocking Biosimilar Benefits: An Exploration of Barriers to Biosimilar Adoption, Value Assessment and Market Sustainability(2023)
Authors: Teresa Barcina Lacosta, Steven Simoens, Isabelle Huys
- A Belgian policy framework for best-value biological medicines(2023)
Authors: Yannick Vandenplas, Isabelle Huys, Steven Simoens, Arnold Vulto
- Balancing Innovation With Optimization in Oncology: Avenues for Bridging the Cancer Clinical Research Gap(2023)
Authors: Robbe Saesen, Isabelle Huys
- Cross-border clinical research in the EU: Fair allocation of data control and responsibility(2023)
Authors: Teodora Lalova-Spinks, Isabelle Huys, Peggy Valcke
- How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action(2023)
Authors: Rosanne Janssens, Liese Barbier, Elise Schoefs, Isabelle Huys
- The impact of policy interventions to promote the uptake of biosimilar medicines in Belgium: a nationwide interrupted time series analysis(2023)
Authors: Yannick Vandenplas, Steven Simoens, Arnold Vulto, Isabelle Huys
- Development of Cell and Gene Therapy Products: Implementation of a Blended Learning Approach(2023)
Authors: Isabelle Huys
Pages: 611 - 611 - Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments(2023)
Authors: Robbe Saesen, Isabelle Huys
- Balancing benefits and risks in lung cancer therapies: patient preferences for lung cancer treatment alternatives(2023)
Authors: Rosanne Janssens, Elise Schoefs, Kristiaan Nackaerts, Isabelle Huys